We are live on ! Find out more
BA

Bristlecone Advisors Portfolio holdings

AUM $1.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
-16.29%
1 Year Est. Return
+19.79%
3 Year Est. Return
+102.73%
5 Year Est. Return
+112.96%
10 Year Est. Return
+315.34%
AUM
$810M
AUM Growth
-$4.59M
Cap. Flow
+$152M
Cap. Flow %
18.76%
Top 10 Hldgs %
39.01%
Holding
251
New
23
Increased
145
Reduced
51
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 18.9%
2 Consumer Discretionary 5.43%
3 Healthcare 4.96%
4 Financials 4.31%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
151
McKesson
MCK
$100B
$621K 0.08%
1,904
+1,020
+115% +$326K
ABT icon
152
Abbott
ABT
$183B
$610K 0.08%
5,612
+397
+8% +$45.1K
IWB icon
153
iShares Russell 1000 ETF
IWB
$47.6B
$606K 0.07%
2,916
+5
+0.2% +$1.13K
SCHA icon
154
Schwab U.S Small- Cap ETF
SCHA
$22.3B
$596K 0.07%
30,554
MRK icon
155
Merck
MRK
$326B
$594K 0.07%
6,518
+1,876
+40% +$166K
GBIL icon
156
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.64B
$589K 0.07%
+5,900
New +$589K
ICE icon
157
Intercontinental Exchange
ICE
$83.5B
$587K 0.07%
6,242
+3,085
+98% +$330K
SFM icon
158
Sprouts Farmers Market
SFM
$7.19B
$573K 0.07%
22,633
+2,899
+15% +$80.5K
SLV icon
159
iShares Silver Trust
SLV
$28.3B
$564K 0.07%
30,239
-30,088
-50% -$627K
KO icon
160
Coca-Cola
KO
$361B
$552K 0.07%
8,771
-50
-0.6% -$3.17K
PFE icon
161
Pfizer
PFE
$141B
$542K 0.07%
10,340
-37
-0.4% -$1.89K
ZS icon
162
Zscaler
ZS
$23.6B
$541K 0.07%
3,619
+1,095
+43% +$194K
ABMD
163
DELISTED
Abiomed Inc
ABMD
$532K 0.07%
2,149
+312
+17% +$84.2K
CVS icon
164
CVS Health
CVS
$136B
$529K 0.07%
5,712
-561
-9% -$54.8K
KOF icon
165
Coca-Cola Femsa
KOF
$22.7B
$515K 0.06%
9,321
+5,270
+130% +$295K
SUI icon
166
Sun Communities
SUI
$15.1B
$513K 0.06%
3,218
+571
+22% +$95.8K
EEMV icon
167
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$512K 0.06%
+9,236
New +$533K
LAND
168
Gladstone Land Corp
LAND
$368M
$501K 0.06%
22,630
-2,467
-10% -$74.5K
XLB icon
169
State Street Materials Select Sector SPDR ETF
XLB
$8.63B
$493K 0.06%
13,408
+8,788
+190% +$368K
COUP
170
DELISTED
Coupa Software Incorporated
COUP
$478K 0.06%
8,370
+4,372
+109% +$337K
IWF icon
171
iShares Russell 1000 Growth ETF
IWF
$119B
$462K 0.06%
8,444
-280
-3% -$16.8K
CCI icon
172
Crown Castle
CCI
$32.8B
$461K 0.06%
2,738
+7
+0.3% +$1.27K
NNN icon
173
NNN REIT
NNN
$9.44B
$460K 0.06%
10,703
+2,030
+23% +$89.3K
PFF icon
174
iShares Preferred and Income Securities ETF
PFF
$13.2B
$456K 0.06%
13,869
BSM icon
175
Black Stone Minerals
BSM
$3.18B
$451K 0.06%
32,913
+6,037
+22% +$91.7K

Similar funds

Bristlecone Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Bristlecone Advisors held 251 positions worth $810M, down 0.56% from $814M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Bristlecone Advisors deployed $152M of net new capital in Q2 2022, opening 23 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,030,982 shares worth $27.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares S&P 500 Growth ETF, an estimated $1.01M trimmed.

  • Bristlecone Advisors's largest Q2 2022 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,030,982 shares worth $27.2M.
  • Bristlecone Advisors added most to Invesco QQQ Trust in Q2 2022, an estimated $26.3M increase.
  • Bristlecone Advisors's biggest Q2 2022 reduction was iShares S&P 500 Growth ETF, cutting an estimated $1.01M.
  • Bristlecone Advisors fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2022, selling an estimated $675K.
  • Bristlecone Advisors's ten largest holdings make up 39% of its $810M portfolio in Q2 2022.
  • Bristlecone Advisors opened 23 new positions and closed 10 in Q2 2022.
  • Bristlecone Advisors's portfolio value fell 0.56% quarter-over-quarter to $810M.

Based on Bristlecone Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.